FAP and neoplasm: Since overexpressing FAP enhances NK92 cell tumor infiltration and lysis in vitro and in vivo (Figs. 6 and7), we speculate that engineering NK cells to overexpress FAP, either in autologous NK cell or NK CAR-NK therapies, could increase NK cell tumor infiltration and lysis.